An inducible caspase 9 safety switch for T-cell therapy.
The efficacy of adoptive T-cell therapy as treatment for malignancies may be enhanced by genetic modification of infused cells. However, oncogenic events due to vector/transgene integration, and toxicities due to the infused cells themselves, have tempered enthusiasm. A safe and efficient means of removing aberrant cells in vivo would ameliorate these concerns. We describe a "safety switch" that can be stably and efficiently expressed in human T cells without impairing phenotype, function, or antigen specificity. This reagent is based on a modified human caspase 9 fused to a human FK506 binding protein (FKBP) to allow conditional dimerization using a small molecule pharmaceutical. A single 10-nM dose of synthetic dimerizer drug induces apoptosis in 99% of transduced cells selected for high transgene expression in vitro and in vivo. This system has several advantages over currently available suicide genes. First, it consists of human gene products with low potential immunogenicity. Second, administration of dimerizer drug has no effects other than the selective elimination of transduced T cells. Third, inducible caspase 9 maintains function in T cells overexpressing antiapoptotic molecules. These characteristics favor incorporation of inducible caspase 9 as a safety feature in human T-cell therapies.
Straathof
Karin C
KC
Center for Cell and Gene Therapy, Baylor College of Meidcine, Houston, TX 77030, USA.
Pulè
Martin A
MA
Yotnda
Patricia
P
Dotti
Gianpietro
G
Vanin
Elio F
EF
Brenner
Malcolm K
MK
Heslop
Helen E
HE
Spencer
David M
DM
Rooney
Cliona M
CM
D000818:Animals; D017209:Apoptosis / Q000187:drug effects; D053453:Caspase 9; D020169:Caspases / Q000235:genetics* / Q000627:therapeutic use; D019281:Dimerization; D004790:Enzyme Induction; D041722:Genes, Transgenic, Suicide; D015316:Genetic Therapy / Q000379:methods*; D006801:Humans; D016219:Immunotherapy, Adoptive / Q000379:methods*; D051379:Mice; D016688:Mice, Inbred NOD; D013601:T-Lymphocytes / Q000378:metabolism / Q000637:transplantation; D022021:Tacrolimus Binding Proteins / Q000627:therapeutic use
C506433:CASP9 protein, human; C506434:Casp9 protein, mouse; D053453:Caspase 9; D020169:Caspases; D022021:Tacrolimus Binding Proteins
J Hematother. 1995 Apr;4(2):73-9
7633844
Nat Biotechnol. 2004 May;22(5):589-94
15064769
J Virol. 1995 Dec;69(12):7430-6
7494248
Nat Med. 1996 Feb;2(2):216-23
8574968
J Exp Med. 1996 Mar 1;183(3):1215-28
8642263
Proc Natl Acad Sci U S A. 1996 Sep 17;93(19):10297-302
8816794
Curr Biol. 1996 Jul 1;6(7):839-47
8805308
Science. 1997 Jun 13;276(5319):1719-24
9180086
Hum Gene Ther. 1997 Jun 10;8(9):1125-35
9189770
Blood. 1998 Sep 1;92(5):1549-55
9716582
Proc Natl Acad Sci U S A. 1998 Sep 1;95(18):10437-42
9724721
J Biol Chem. 1999 Mar 26;274(13):8359-62
10085063
Hum Gene Ther. 1999 Sep 20;10(14):2273-85
10515447
Hum Gene Ther. 2000 Mar 1;11(4):611-20
10724039
J Immunol. 2000 Apr 15;164(8):3950-4
10754284
Proc Natl Acad Sci U S A. 2000 Aug 1;97(16):9150-5
10908661
Eur J Immunol. 2000 Oct;30(10):2765-74
11069056
Blood. 2001 Jan 1;97(1):63-72
11133743
Blood. 2001 Mar 1;97(5):1249-57
11222367
Virology. 2001 Mar 1;281(1):43-50
11222094
Nature. 2001 Mar 1;410(6824):112-6
11242052
J Clin Pharmacol. 2001 Aug;41(8):870-9
11504275
Proc Natl Acad Sci U S A. 2001 Dec 4;98(25):14250-5
11734640
Adv Cancer Res. 2002;84:175-201
11883527
Blood. 2002 May 1;99(9):3179-87
11964281
Biochem Biophys Res Commun. 2002 Jun 14;294(3):714-8
12056829
Nat Rev Immunol. 2002 Jul;2(7):512-9
12094225
Cancer Invest. 2002;20(5-6):737-48
12197230
Cancer Res. 2002 Sep 1;62(17):4968-76
12208748
Science. 2002 Oct 25;298(5594):850-4
12242449
Gene Ther. 2002 Dec;9(23):1633-8
12424616
Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2742-7
12601144
Mol Cell. 2003 Feb;11(2):529-41
12620239
Cancer Sci. 2003 Jan;94(1):87-91
12708480
Gene Ther. 2003 Jul;10(14):1189-97
12833128
Cytotherapy. 2003;5(3):211-26
12850789
Curr Opin Cell Biol. 2003 Dec;15(6):725-31
14644197
Curr Opin Oncol. 2004 Jan;16(1):19-24
14685088
Cancer Gene Ther. 2004 Feb;11(2):81-91
14685154
Blood. 2004 Feb 15;103(4):1261-9
14563634
Hum Gene Ther. 2004 Jan;15(1):63-76
14965378
Hum Gene Ther. 2004 Mar;15(3):305-11
15018739
N Engl J Med. 1995 Oct 19;333(16):1038-44
7675046